FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cytarabine Liposome (DepoCyt) Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Pacira Pharmaceuticals, Inc. (New 07/24/2017)

Company Contact Information:

Presentation Posting Date Related Information
DepoCyt® (cytarabine liposome injection), 50 mg (5 mL single-dose vials)(NDC 57665-331-01) 07/24/2017 Product is permanently discontinued due to product-specific supply issues.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English